- The Institute
- Travel & Vaccines
- Alumni & Friends
Research for Global Health in Hamburg
Today, the infectious disease epidemiologist Jürgen May took over the leadership of the Bernhard Nocht Institute for Tropical Medicine (BNITM), the largest research institute for global infections in Germany. The coronavirus pandemic shows how important it is to research pathogens and that experience in the fight against infectious diseases is more important than ever. The Bernhard Nocht Institute in Hamburg is one of the oldest institutions for tropical medicine worldwide.
Ebola can apparently reappear years later
Conakry/ Hamburg, September 15th, 2021 – Contrary to previous assumptions, Ebola virus epidemics do not necessarily originate from animal transmissions. The most recent outbreak in Guinea can be traced back to the epidemic in West Africa from 2014 to 2016. This is what an international team involving researchers from Guinea, France, Senegal, Great Britain, Switzerland, Belgium, the USA, and Germany has discovered. A corresponding publication has appeared in the renowned scientific journal Nature. The Bernhard Nocht Institute for Tropical Medicine (BNITM) is involved with prominent authorship.
BNITM: Monitoring mosquito populations an important part of epidemic early warning systems
Rising global temperatures are enabling heat-loving mosquito species such as the Asian tiger mosquito to colonise new habitats. At the same time, infections with tropical viruses transmitted by mosquitoes are also increasingly found in Europe and Germany. In recent years, for example, there have been several outbreaks of chikungunya and dengue fever in southern Europe and repeated infections with Usutu and West Nile viruses in Germany.
BNITM raises rainbow flags and signs Diversity Charter
As of today, rainbow flags are also flying at the Bernhard Nocht Institute for Tropical Medicine (BNITM) as a sign of respect and acceptance of gender and sexual diversity. In addition, the Board of Directors has signed the Diversity Charter, an initiative to promote diversity in companies, educational institutions, administrations and civil society organisations.
Large clinical trial in five African countries yields important safety data for pyronaridine artesunate
Scientists around the world are searching for drugs to better treat malaria patiens. Great hopes are pinned on the combination drug Pyramax. In clinical trials, it proved to be highly effective and safe. However, some patients experienced temporarily elevated liver enzymes during clinical development. An international cross-institutional group of researchers therefore undertook a large-scale study in Africa on the safety, tolerability and efficacy of pyronaridine artesunate for the treatment of uncomplicated malaria under real-life conditions. The results are promising and have just been published in the journal PLOS Medicine.
Die Deutsche Gesellschaft für Tropenmedizin, Reisemedizin und Globale Gesundheit e.V. (DTG) verleiht alle zwei Jahre den “Preis für Tropenmedizin“. Der Preis dient der Förderung jüngerer Wissenschaftler:innen und wird für besondere wissenschaftliche Leistungen auf dem Gebiet der Tropenmedizin oder der internationalen Gesundheitswissenschaften verliehen. Er ist mit 5.000 Euro dotiert und wird derzeit von der Else-Kröner-Fresenius-Stiftung finanziert.
At the first digital Summer School of the Leibniz Center Infection on the topic "Molecular biology of pathogens", PhD students from the Bernhard Nocht Institute for Tropical Medicine (BNITM), the Research Center Borstel - Leibniz Lung Center (FZB) and the Leibniz Institute for Experimental Virology (HPI) came together for a two-day digital meeting to exchange ideas on current topics in infection biology.
Cross-institutional research group adds important molecular biology puzzle piece to explanation
Malaria is known to be a severe and fatal disease in Africa especially in children under five. Due to the much smaller number of cases, the causes of severe disease in adults have so far been insufficiently researched. A cross-institutional research group led by Dr. Anna Bachmann in the Department of Cellular Parasitology at the Bernhard Nocht Institute for Tropical Medicine (BNITM) has now been able to analyse the malaria cases of 32 adults who suffered from varying degrees of malaria. The researchers found important differences between children and adults in the binding of malaria-infected red blood cells to the blood vessel walls. The results were recently published in the scientific journal eLife.
Dr. Sophie Duraffour from the Department of Virology at the Bernhard Nocht Institute for Tropical Medicine (BNITM) receives the "Clinical Research" award of the GlaxoSmithKline Foundation. The prize is endowed with 10,000 euros. It is awarded in recognition of outstanding scientific work.
Worm infections are among the most common tropical diseases worldwide. Parasitic worms are such successful infectious agents partly because they are able to weaken the immune response of their host. But the host also knows what to do: It reacts with a complex interplay of different messenger substances of the immune system.